Anti-EF-2/EEF2 Antibody, clone 1E7 ZooMAb^® Rabbit Monoclonal

We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

Clone 1E7 is a ZooMAb^® Rabbit recombinant monoclonal antibody that specifically detects Elongation factor 2 (EF-2). It targets an epitope within 19 amino acids from the C-terminal region.

KLH-conjugated linear peptide corresponding to 19 amino acids from the C-terminal region of human Elongation factor 2 (EF-2).

Quality Control Testing

Evaluated by Western Blotting in C6 cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected EF-2/EEF2 in C6 cell lysate.

Tested Applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected EF-2/EEF2 in HCT116, MCF7, and NIH3T3 cell lysates.

Affinity Binding Assay: A representative lot of this antibody bound EF-2/EEF2 peptide with a KD of 4.0 x 10-6 in an affinity binding assay.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected EF-2/EEF2 in human kidney tissue sections.

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected EF-2/EEF2 in A431, HeLa, HepG2, and NIH 3T3 cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Elongation factor 2 (UniProt: P13639; also known as EF-2) is encoded by the EEF2 (also known as EF2) gene (Gene ID: 1938) in human. EF-2 is a GTP-binding protein that is shown to be essential for protein synthesis. It catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational to the post-translocational state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. EF-2 is completely inactivated when phosphorylated EF-2 kinase. EF-2 kinase is inhibited when phosphorylated at serine 366 by the action of p70S6 kinase. Unphosphorylated EF-2 bound to ribosomes is not accessible to EF-3 kinase. Phosphorylation of EF-2 on tyrosine 265 and 373 by C-terminal Src kinase (Csk) is reported to promote its cleavage and SUMOylation-dependent nuclear translocation. However, this phosphorylation does not affect the function of EF-2 in protein translation. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Yao, Q., et al. (2014). J. Biol. Chem. 289(18); 12666-12678; Moldave, K. (1985). Annu. Rev. Biochem. 54; 1109-1149).

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.